GONADAL HORMONES ACT ON HYPOTHALAMIC and limbic sites in the male rodent brain, promoting sexual behavior. Moreover, mating-induced Fos immunoreactivity (-ir) [a marker of neuronal activity (43) ] is expressed in neurons that contain gonadal steroid receptors, suggesting that a brain neural network, composed of interconnected, steroid-sensitive neurons, mediates male mating behaviors. The distribution of forebrain neurons that project to the prostate gland (44, 48, 71) overlaps to a considerable extent with that of the distribution of matinginduced Fos-ir, raising the possibility that the same neurons that mediate mating behavior also control the prostate gland. It is not known at present, however, whether the forebrain neurons labeled after inoculation of the prostate gland with a transneuronal viral tract tracer, the pseudorabies virus (PRV; Bartha strain), contain gonadal steroid receptors. Two areas of overlap are the medial preoptic area (MPO) and bed nucleus of stria terminalis (BST) (31, 42) . Anatomic studies have shown that these areas and the medial amygdala (MEA), which, same as for the MPO and BST, also mediate male sexual behaviors (28, 34) , are reciprocally interconnected (7, 14, 15, 55) . Neurons in each of these brain regions contain either androgen receptors (AR) alone or estrogen receptors (ER) alone, or both receptor types (23, 54) . Male sexual behavior is altered or attenuated when steroid hormone receptor antagonists to AR or ER are administered into the MPO or the MEA (and likely the BST) (39 -41, 63) . Male sexual behavior is also reduced by inactivation of the aromatase enzyme, which converts testosterone to estradiol (E 2 ) (45), reinforcing the importance of both androgenic and estrogenic actions in the brain (5, 12, 28, 29, 49, 53) . Therefore, because immunohistochemical (IHC) studies have indicated that mating-induced Fos-ir is colocalized with either ER-ir or AR-ir or both in several brain areas that also contain neurons that project to the prostate gland (23, 44, 48, 71) , we hypothesized that a single steroid-sensitive brain network both mediates male copulatory behavior and controls the prostate gland. The interconnected brain regions that make up this steroid-sensitive network may synchronize and coordinate sexual behavioral responses with physiological responses of the prostate gland, the penis, and other reproductive organs associated with insemination.
To test the hypothesis, we injected PRV, which labels entire circuits within the same animal through its infection of only functionally connected neurons [i.e., synaptically connected neurons (8, 9, 56) ], into the prostate gland, a peripheral structure activated during mating. We chose to infect the prostate gland with PRV because the expulsion of prostatic fluid temporally is synchronized with the ejaculatory behavioral pattern, suggesting that activity in a common supraspinal circuit may trigger both the expulsion of prostatic fluid and the behavioral patterns associated with mating behavior. In addition, to our knowledge, this is the only function of the prostate gland, thus ensuring labeling of a circuit that only functions to secrete prostatic fluid with ejaculation (42) . Therefore, we reasoned that PRV would infect the central neural network underlying mating behavior, and we additionally predicted that this network would be composed of steroid-sensitive neurons. This was accomplished by processing the brains for PRV-ir and either ER-ir or AR-ir. The anti-AR antibody PG-21 (51) and the anti-ER antibody 1D5 were chosen for this work because PG-21 is commonly used to located AR-ir neurons in the brain and because the 1D5 antibody was raised against ER-␣ (32). Knockout studies in mice have suggested that ER-␣ is the major ER subtype that mediates male sexual behavior (47, 52) . The lack of a validated and effective ER-␤ antibody precluded analysis of this important ER subtype.
MATERIALS AND METHODS

Animals
Male (371-605 g) Sprague-Dawley rats, at least 70 days old, were obtained from Charles River Laboratories (Raleigh, NC). Animals were housed singly in polycarbonate cages, 22 ϫ 44 ϫ 18 cm, and given free access to food and water in the university vivarium on a 14:10-h reversed light-dark cycle (lights off at 0930 eastern standard time). All housing and experimental procedures were approved by the Georgia State University Institutional Animal Care and Use Committee and were in accordance with National Institutes of Health guidelines.
PRV Injection and Dissection
Males were anesthetized with pentobarbital sodium (40 mg/kg ip; Veterinary Laboratories, Lenexa, KS), and the prostate gland was exposed via a small ventral incision directly over the bladder. PRV (14 l; 3 ϫ 10 8 plaque forming units/l) was injected into the rat prostate glands with a microsyringe. Specifically, to each animal (n ϭ 20), 14 l of PRV were delivered into the two prostatic lobes as follows: 7 l of PRV were distributed into the first lobe by injection of 1 l followed by holding the syringe in place for at least 1 min and then slightly moving the syringe to inject the next 1 l at a different site in the lobe. Thereafter, a second prostatic lobe was identically injected with PRV as in the first lobe. This injection technique ensures that it is highly likely that PRV was confined only to the prostate gland and did not encroach into the abdominal cavity or adjacent sites. Animals were monitored daily for signs of infection or urinary discomfort. After 7 days, animals were given a lethal dose of pentobarbital sodium (100 -150 mg/kg) and perfused transcardially with physiological saline followed by a minimum of 300 ml of 4% paraformaldehyde. The craniums were partially opened and immersed in the same perfusion fixative. The next day, brains were removed from skulls and transferred to 30% sucrose in 0.1 M sodium phosphate buffer (PB; pH 7.4) where they remained for 3 days. Brains were immersed in 0.1 M PB overnight, cut on a coronal plane into 40-m sections on a freezing stage sliding microtome, and stored in 0.1 M PB. Standard IHC was used (see below) to visualize infected neurons.
IHC
Dual labeling for ER-ir and PRV-ir. Sections were rinsed in 0.1 M PB followed by a 24-h incubation in a blocking solution of 0.1 M PB ϩ 0.4% Triton X-100 (TX) ϩ 5% normal goat serum (NGS) (Jackson Laboratories, Bar Harbor, ME) at room temperature with agitation. Sections were then sequentially incubated with two different primary antibodies: first with the rabbit polyclonal anti-PRV antibody (RB132; a generous gift of Dr. Lynn Enquist, Princeton University) diluted 1:10,000 in a solvent of 2% NGS and 0.1% sodium azide in 0.1 M PB ϩ 0.4% TX for 24 h at room temperature with agitation, and second with the 1D5 mouse monoclonal anti-ER antibody (catalogue no. 18-7149, 1 g/ml; Zymed Laboratories, South San Francisco, CA) in a mixture of 2% NGS in 0.1 M PB ϩ 0.4% TX for 48 h at room temperature with agitation. After washes with 0.1 M PB (3 ϫ 5 min), sections were incubated in a mixture of two secondary antibodies: 1) biotinylated goat anti-rabbit secondary antibody (1:350 dilution, catalogue no. BA-1000, lot no. A0708; Vector Laboratories, Burlingame, CA) and 2) gold-conjugated goat anti-mouse secondary antibody (1:200 dilution, catalogue no. 115-185-100, lot no. 44811; Jackson Laboratories) in a solution of 0.1 M PB ϩ 0.4% TX ϩ 3% NGS for 2 h at room temperature with agitation. For the peroxidase reaction, sections were washed 3 ϫ 5 min in 0.1 M PB, incubated in one-tenthstrength avidin-biotinylated peroxidase complex (Vectastain Elite standard ABC peroxidase kit, Vector Laboratories) in 0.1 M PB for 60 min at room temperature with agitation, washed in 0.1 M PB (3 ϫ 5 min), and then incubated in a mixture of 0.2 mg/ml diaminobenzidine (Sigma, St. Louis, MO) and 0.1 l/ml H 2O2 (Sigma) in 0.1 M PB for 5 min at room temperature. For the silver-enhancement reaction, sections were washed in deionized water (3 ϫ 5 min), incubated in silver-enhancement reagents (BBI silver enhancement kit; Ted Pella, Redding, CA, prepared according to the manufacturer's directions) for 20 min at 4°C, and then washed again in deionized water (3 ϫ 5 min). Finally, after additional washes in 0.1 M PB (3 ϫ 5 min), sections were mounted onto gel-coated slides, dehydrated in alcohol, cleared with xylene, and coverslipped with DPX mounting medium. Positive control sections from previously verified PRV-infected animals were included in each assay.
Dual labeling for AR-ir and PRV-ir. Sections adjacent to those used in the ER ϩ PRV-ir IHC assay were dually processed for AR-ir and PRV-ir in a similar manner, with a few exceptions. At the appropriate steps in the procedure, sections were sequentially incubated with two different primary antibodies: first with a porcine polyclonal anti-PRV antibody (1:30,000, generous gift of Dr. Lynn Enquist) in a solvent of 5% NGS in 0.1 M PB ϩ 0.4% TX, for 24 h at 4°C, and second with the PG-21 rabbit polyclonal anti-AR antibody (3 g/ml, catalogue no. 06 -680, lot no. 24732; Upstate USA, Charlottesville, VA) in the same solvent for 48 h at 4°C. Sections were then washed in 0.1 M PB (3 ϫ 5 min) and incubated in a mixture of two secondary antibodies: 1) biotinylated goat anti-swine secondary antibody (1:200; Vector BA-9020, lot no. K0223) and 2) gold-conjugated goat anti-rabbit secondary antibody (1:200; BBI LM.GAR5, batch no. 2697). Incubation was in a solution of 0.1 M PB ϩ 0.4% TX ϩ 5% NGS for 2 h at room temperature with agitation. Positive control sections from previously verified PRV-infected animals were also included.
IHC controls. Additional sections from each rat were processed in both the ER ϩ PRV-ir and the AR ϩ PRV-ir IHC assays, as above, but without any primary antibodies (zero primary antibody negative controls), resulting in no labeling. Other sections were used as controls to test for cross-reactions between primary and secondary antibodies. The cross-reaction control sections were processed as above except that they were incubated with only one of the primary antibodies and both secondary antibodies. Specifically, 1) RB132 was incubated without 1D5, 2) 1D5 was incubated without RB132, 3) the porcine anti-PRV antibody was incubated without PG-21, and 4) PG-21 was incubated without the porcine anti-PRV antibody.
Imaging and Quantification
For each brain section, digital serial photomicrographs were made at sufficiently high resolution to visualize the individual labeled neurons (Fig. 1) . These photomicrographs were then melded together via a computer imaging program (Photoshop version 6.0) to make one image. The resulting composite photomicrograph was then magnified, and section boundaries and major landmarks were traced onto it, as were the locations of cells staining positive for PRV-ir (with and without AR-ir or ER-ir). These tracings, with plotted cell locations, were mapped onto matching standard rat brain atlas plates by superimposing the tracings over the atlas plates and transferring the positions of the labeled cells to the plates. Cells were then counted visually from these atlas plates by using the regional boundaries and nomenclature of Swanson (60) .
RESULTS
IHC Cross-Reaction Controls
The IHC cross-reaction controls produced single labeling only, indicating that each primary antibody reacted normally with the appropriate secondary antibody and did not cross-react with the other secondary antibody and that the secondary antibodies did not cross-react with each other. No dual-labeled or inappropriately single-labeled neurons were found in any of these control tissue sets.
PRV Infections
PRV successfully infected 11 of 20 rats. Because there was considerable individual variation in the extent of PRV-ir neuronal labeling among the 11 rats that developed infections, the 4 cases most heavily labeled by PRV-ir, but showing no lysis at any level of the neuroaxis, were mapped and quantified in their entirety (Tables 1 and 2 ). The remainder of the PRV-ir labeled cases (n ϭ 7 rats) was not quantified because PRV-ir neuronal labeling was sparse (e.g., fewer than 5 PRV-ir neurons in the MPO).
In the diencephalic area of the brain, PRV-ir was localized in several hypothalamic nuclei, notably the anterior hypothalamus, BST, suprachiasmatic nucleus, hypothalamic paraventricular nucleus (PVH), median preoptic area, MPO, medial preoptic nucleus (MPN), retrochiasmatic hypothalamus, lateral hypothalamus (LH), dorsomedial hypothalamus, ventromedial hypothalamus (VMH), and posterior hypothalamus (PH). Other areas exhibiting PRV infections were the premammallary nucleus, arcuate nucleus, ventral tegmental areas, zona incerta (ZI), periaqueductal gray (PAG), central nucleus of the amygdala (CEA), and MEA. Fig. 2A) , PRV-ir single-labeled neurons (Fig. 2B) , and PRV ϩ ER-ir dual-labeled neurons (Fig. 2C) were found in all mapped cases. Injection of PRV into the prostate gland produced selective labeling in the brain (Figs. 3 and 4) . PRV-ir labeling, with and without ER-ir, was consistently present in the MPO (including the MPN), the BST, PVH, and ZI, as well as in a continuum of cells in the perifornical area that extended through the LH to the PH. Sparser and/or inconsistent PRV-ir labeling was also noted in the CEA, MEA, VMH, and PAG.
Distribution of PRV-ir and ER-ir labeling. Examples of ER-ir single-labeled neurons (
Distribution of PRV-ir and AR-ir labeling. AR-ir singlelabeled neurons (Fig. 2D) , PRV-ir single-labeled neurons (Fig.  2E) , and PRV ϩ AR-ir dual-labeled neurons (Fig. 2F) were found in all mapped cases. The distribution of PRV-ir labeling, with or without AR-ir, matched very closely the distribution described above for PRV-ir, with or without ER-ir, even though different anti-PRV primary antibodies were used. This distribution is depicted for two cases in Figs. 5 and 6. To facilitate comparisons between the distribution of PRV ϩ AR-ir labeling and that of PRV ϩ ER-ir, Figs. 3 and 5 are from one animal and Figs. 4 and 6 are from a different animal. PRV-ir labeling, with and without AR-ir, was consistently present in the MPO (including the MPN), BST, PVH, and ZI, as well as in a continuum of perifornical cells in the LH to the PH. This labeling was less consistently present and/or sparser in the CEA, MEA, VMH, and PAG.
Quantification of dual labeling. For each of the four mapped cases, the total counts of PRV-ir neurons and the percentages of those that also expressed ER-ir are presented in Table 1 . Total counts of PRV-ir neurons and the percentages that were AR-ir are presented in Table 2 . In the MPO, MPN, BST, and PVH, there was a high degree of both ER-ir and AR-ir labeling in PRV-ir neurons.
DISCUSSION
Inoculation of the prostate with PRV labeled the central origins of the autonomic outflow circuits, which are commonly seen after PRV injection of other peripheral autonomic targets, such as the PVH and VMH (57) . Most importantly, PRV-ir was expressed in several additional brain areas that previously have been shown to mediate male mating behavior, specifically the MPO, BST, ZI, and PAG. Moreover, in these areas and also in the PVH, the majority of PRV-ir cells also expressed either ER-ir or AR-ir. Thus it appears that the neural circuitry underlying prostatic control includes steroid receptor-containing diencephalic neurons located in brain regions that mediate male sexual behavior and that may be involved with the terminal consummatory aspects of mating. This is consistent with the hypothesis that a steroid-responsive neural network governs both male copulatory behavior and the prostate gland. Moreover, the present findings reinforce earlier reports that mating-induced Fos-ir is colocalized with steroid receptors in neurons in these same brain areas (23) .
Male mating behavior is thought to be controlled by a supraspinal neuronal network that integrates exogenous and endogenous cues, and the brain areas, implicated in previous research as important for male mating, correlate well with brain areas labeled by PRV-ir in the present study. In this study, we labeled a diencephalic circuit by inoculating the prostate gland with PRV and found that many PRV-ir neurons in the MPO, MPN, BST, ZI, and PAG expressed steroid receptors. The distribution of labeling of the neurons projecting to the prostate gland in this study agrees well with previous studies in which PRV was injected into the prostate gland (48, 71) or prostate gland and urinary bladder (44) . To our knowledge, however, and most importantly, this is the first study demonstrating the presence of gonadal steroid receptor immunoreactivity in the neurons comprising the circuit from the brain to the prostate gland. Moreover, the PRV-ir circuit exhibits certain features suggesting it may function in reproductive behavior, specifically that it contains steroid receptors in brain areas known to mediate mating and is connected with peripheral structures involved in mating.
It is universally accepted that the MPO plays a central role in the expression of vertebrate male sexual behavior. Lesions of the MPO or of the MPN reduce (11, 26, 35, 59 ) and stimulation of the MPO facilitates (17, 18, 37, 64) male mating behavior. Lesions of the BST and/or the stria terminalis (a fiber tract connecting the amygdala with the hypothalamus) interrupt male mating to a lesser extent than do lesions of the MPO, typically by affecting the cadence of mating, resulting in increased frequencies of behaviors preceding ejaculation and longer latencies until ejaculation occurs (19, 21, 62, 70) . Lesions of the ZI virtually eliminate male mating behavior (36) . Studies that combined PAG lesions with MPO stimulation suggest that the descending pathway for male sexual behavior passes through the PAG from the MPO (38) . The structures implicated functionally in the control of male sexual behavior were also double labeled in the present study with PRV-and AR-or ER-ir.
PRV-ir labeling also occurred in some brain areas that traditionally have not been associated with male mating. Heavy PRV-ir occurred in all of the neuroanatomic subdivisions of the PVH and in a continuum of perifornical cells through the LH and PH. This is not unexpected because these brain areas are involved in control of numerous autonomic targets and because many sexual responses have an autonomic component; these include cardiovascular responses, blood vessel dilatation and constriction, glandular emissions, secretions from seminal vesicles, and contraction of the prostate and vas deferens and other reproductive organs (42) . Interestingly, mating-induced Fos-ir has been reported in the PVH of male rats (4, 27, 33, 67) . Moreover, lesions of the parvocellular PVH are associated with a "decrease in seminal emission at the time of ejaculation" (1), and there are suggestions that the PVH might be involved in the supraspinal control of ejaculation (67) . Moreover, some PVH neurons project to the spinal nucleus of bulbocavernosus (65, 66) , a spinal cord area that regulates penile reflexes (6), and several studies have suggested that the descending oxytocinergic neurons of the PVH play a role in male sexual behavior (2, 10, 30) . Many PRV-ir neurons in the PVH showed ER-ir or AR-ir, consistent with a role in regulation of mating behavior, and it is noteworthy that the anti-ER antibody used in this study recognizes ER-␣, which is the ER subtype suggested as being important in male sexual behavior (47, 52) . Although the PVH contains appreciable quantities of ER-␣ (20), ER-␤ has been reported to predominate in the PVH (58) , but this study does not address the question of whether ER-␤ colocalizes with PRV-ir.
The MEA and the central tegmental field (also known as the posterior subparafascicular nucleus of the thalamus; CTF/ SPFp) showed little or no PRV-ir. This was unexpected because both areas are known to have direct reciprocal connections to the MPO and both express mating-induced Fos-ir colocalized with steroid hormone receptors (23) (24) (25) . We expected to see dense PRV-ir in steroid-sensitive neurons of the MEA because the posterodorsal nucleus of the MEA is specifically activated by ejaculation (14) and because previous studies from our laboratory demonstrated that E 2 implants to the MEA promote mounting and intromission (28), whereas inhibiting the conversion of E 2 from testosterone in the amygdala (29) causes severe deficits in mating. The amygdala, however, also appears to have additional roles in the expression of male mating, such as the processing of pheromonal and chemosensory cues vital for mating (46) . These sensory and integrative functions, which are hormone dependent, suggest that the amygdala interfaces with brain areas that mediate the motor aspects of mating and might modulate activity in the MPO. However, cells in the amygdala were not reliably PRV labeled in this study, and it is unlikely that, given more time, cells in the amygdala would have become PRV infected because the 7-day survival period used in this study should have been sufficiently long to permit PRV to progress throughout the forebrain. Instead, it is more likely that the amygdala simply is not a major element in the PRV-ir circuit described here. Although the PRV-ir circuit described here might only control prostatic functions, if it also plays a behavioral role, then these findings may have implications for the organization of the neural circuits underlying male mating behavior. That is, conceivably, the neural circuits mediating appetitive aspects of mating (e.g., mounting and intromission) or sensory feedback from ejaculation are independent of those mediating consummatory aspects of mating (e.g., the ejaculatory pattern), where neurons in the MEA are contained in the former circuit(s) and the PRV-ir cells identified here are contained in the latter circuit(s). Such dissociation between sexually relevant neural circuits has been previously reported in female rats in which "different sexual stimuli may be integrated through distinct ER-containing circuits in the rostral MPO and postrodorsal medial amygdala" (22) . In this regard, it is noteworthy that E 2 stimulation of the male rat amygdala promotes mounting and intromission only and does not maintain ejaculatory performance (28) . This is consistent with mating-induced Fos-ir expression in the MEA of male hamsters at sexual satiety, suggesting that this brain area responds to sensory feedback from ejaculation but does not contribute to the motor control of ejaculation (13) .
A series of recent studies has defined a spinal ejaculationgenerating center in the lumbar spinal cord (13, 61) , highlighting a set of neurons that are specifically activated by ejaculation. PRV studies have shown that these cells receive input from the prostate and bulbospongiosus muscle, supporting the idea that a spinal-generating center coordinates emission and ejaculation (68, 69) . These lumbar neurons send ascending projections rostrally through the spinal cord and terminate in the CTF/SPFp, which has reciprocal connections to the MPO (24, 25) . The MPO is heavily reciprocally connected to the BST and MEA; thus these ascending spinal neurons are in a position to transmit ejaculatory information to the brain. Although the lack of PRV-ir labeling in the CTF/SPFp is surprising, it is noteworthy that CTF/SPFp neurons are activated (i.e., express mating-induced Fos-ir) in response to ejaculation (13) , suggesting that some genital/somatosensory feedback information is conveyed to the CTF/SPFp by a route that is independent of the motor circuits controlling prostatic functions. Therefore, at least some neurons in the CTF/SPFp, similar to those in the MEA, may be components in a neural circuit that is independent of the PRV-ir circuit described here.
Mating behavior does not always end in ejaculation. Not all mounting behavior leads to intromission, and not all mounts with intromission lead to ejaculation. Because gonadal steroid hormones must act in the brain for mounting to be initiated, presumably a steroid-responsive brain network integrates exogenous sensory cues with the motor output needed to initiate mating behavior (e.g., mounting and intromission). Activity in this network may then lead to activity in independent circuits that, in all probability, synchronize both the autonomic motoneurons and also the skeletal motoneurons necessary for ejaculation. Perhaps primary somatosensory feedback is constantly being received and integrated in the brain, which, in turn, signals peripheral structures that coordinate mating postures and insemination. Such central-peripheral-central circuits and their mechanisms of hormonal regulation are not yet fully understood, but Fos-ir labeling patterns and hormone manipulation studies have predicted a circuit for the initiation of mating made up of steroid-responsive neurons. The PRV-ir labeling patterns observed in this study provide evidence consistent with this idea. Collectively, we have identified a steroid receptor-containing, supraspinal neuronal circuit that may contribute to the consummatory motor aspect of mating and that may synchronize autonomic and behavioral reproductive responses.
